Avidity Biosciences, Inc. Profile Avatar - Palmy Investing

Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead produc…

Biotechnology
US, San Diego [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of RNA's Analysis
CIK: 1599901 CUSIP: 05370A108 ISIN: US05370A1088 LEI: - UEI: -
Secondary Listings
RNA has no secondary listings inside our databases.